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a b s t r a c t
Whole saliva is a multiglandular secretion complex consisting of gingival fluid, desqua-
mated epithelial cells, microorganisms, products of bacterial metabolism, food debris, 
leukocytes mucus from the nasal cavity and the pharynx. Saliva has many functions, 
including tissue repair, tamponage, protection, digestion, taste, antimicrobial action, 
maintaining tooth integrity and antioxidant defense system. A decrease in salivary flow 
(hyposalivation) is a common disorder and it is estimated that approximately 20% of the 
general population have this alteration.
Hyposalivation may be due to diabetes mellitus, hypothyroidism, dehydration, impaired 
glandular parenchyma by infectious processes, granulomatous diseases or autoimmune 
and inflammatory conditions (such as Sjögren’s syndrome and rheumatoid arthritis), 
radiotherapy of head and/or neck region, or it may be associated with mood disorders, 
adverse effects caused by the use of some medications or even be idiopathic. Conven-
tional therapies for the treatment of reduced saliva flow with the use of chemical and 
gustatory secretagogues are still limited.
However, new alternatives have shown great perspective in the treatment of this di-
sorder. To diagnose a patient as having chronic hyposalivation is a challenge in clinical 
practice and methods of salivary flow assessment are little known by rheumatologists. 
The serial evaluation of salivary flow is important for the diagnosis and prognosis of 
certain oral and systemic conditions. This review addresses some aspects related to 
the role of saliva, the consequences of hyposalivation and methods of salivary flow rate 
measurement, useful concepts in the daily practice of rheumatology. 
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
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r e s u m o
A saliva total é um complexo de secreções multiglandulares composto de fluido gengi-
val, células epiteliais descamadas, microrganismos, produtos do metabolismo bacteriano, 
resíduos alimentares, leucócitos, muco da cavidade nasal e da faringe. A saliva possui di-
versas funções, incluindo reparação tecidual, tamponamento, proteção, digestão, gustação, 
ação antimicrobiana, manutenção da integridade do dente e sistema de defesa antioxi-
dante. A redução do fluxo salivar (hipossalivação) é um distúrbio comum, e estima-se que 
cerca de 20% da população geral tenham esta alteração. 
A hipossalivação pode ser decorrente de diabetes mellitus, hipotireoidismo, desidratação, 
comprometimento do parênquima glandular por processos infecciosos, doenças granulo-
matosas ou condições autoimunes e inflamatórias (como a síndrome de Sjögren e a artrite 
reumatoide), radioterapia da região cefálica e/ou cervical, bem como pode estar associada a 
distúrbios do humor, efeitos adversos ocasionados pelo uso de algumas medicações ou, ainda, 
ser de causa idiopática. As terapias convencionais para o tratamento da redução do fluxo sali-
var, com o uso de sialogogos gustatórios e químicos, ainda apresentam restrições. 
Contudo, novas alternativas têm mostrado grande perspectiva no tratamento deste prob-
lema. Diagnosticar um paciente como hipossalivador crônico é um desafio na prática clíni-
ca, e os métodos de avaliação do fluxo salivar são pouco conhecidos pelos reumatologistas. 
A avaliação seriada do fluxo salivar é importante para o correto diagnóstico e prognóstico 
de determinadas condições bucais e sistêmicas. Esta revisão aborda alguns aspectos rela-
cionados à função da saliva, às consequências da hipossalivação e aos métodos de medição 
da taxa de fluxo salivar, conceitos úteis na prática diária do reumatologista.
© 2013 Elsevier Editora Ltda. All rights reserved.
Introduction
Saliva is a mixture of fluids secreted mainly by the three 
pairs of major salivary glands: parotid, submandibular, and 
sublingual. The 400 to 500 small salivary glands distributed 
over the buccal mucosa (except in the gums and anterior half 
of the hard palate), lips, and along the mucosa of the upper 
aerodigestive tract, present in the nasal cavity to the larynx 
and pharynx, also participate in this secretion.1,2 Together, 
they are responsible for the remaining 5% of saliva secreted 
by humans.3 The saliva secreted by the major glands differs 
in composition; it is considered that humans secrete approxi-
mately 0.5 liters of saliva per day in response to stimulation 
of the sympathetic and parasympathetic autonomic nervous 
system.4
A reduction in salivary flow (hyposalivation) is a common 
disorder: it is estimated that approximately 20% of the general 
population have this alteration.5 It is natural for humans to go 
through short periods of hyposalivation, and its occurrence is 
frequent when individuals are under psychological stress.6,7 
Changes of fluids and electrolytes, as occurring in diabetes 
mellitus, hypothyroidism, and low hydration can also cause 
reduced salivary flow. However, hyposalivation may be due 
to multiple causes, which may include involvement of the 
glandular parenchyma by infectious, inflammatory process-
es, whether associated or not with granulomatous diseases 
or autoimmune conditions (such as Sjögren’s syndrome and 
rheumatoid arthritis);2,8 radiotherapy of the head and/or cer-
vical region;9,10 or it may be associated with mood disorders;6 
adverse effects caused by the use of some medications;6 or it 
can also be idiopathic.11 The decrease in flow and alterations 
in salivary composition affects 25% of the elderly population, 
and complaints of oral and systemic discomfort due to these 
alterations are common.12
Conventional therapies for the treatment of reduced sali-
vary flow using chemical and gustatory secretagogues are still 
limited. However, new alternatives have shown great perspec-
tive for the treatment of this disorder.13,14 
To diagnose a patient with chronic hyposalivation is a 
challenge in clinical practice,15 due to lack of medical records 
indicating the patient’s salivary pattern.16 However, the serial 
assessment of salivary flow is important for the diagnosis and 
prognosis of certain oral and systemic conditions.17,18 It has 
been stated that health professionals have not yet adopted 
this practice due to the lack of availability of simple evalua-
tion procedures.18-20 As a result, hyposalivation goes undiag-
nosed in asymptomatic patients. Conversely, some patients 
may be misdiagnosed as having dry mouth when xerostomia 
(dry mouth sensation) is not accompanied by a decrease in 
the salivary secretion rate.21
This review aimed to address some issues related to the 
role of saliva, the consequences of hyposalivation, and meth-
ods of salivary flow rate measurement, which are useful con-
cepts in the daily practice of rheumatology. 
Functions of saliva
Saliva has many functions (Table 1) related to the mainte-
nance of oral and systemic integrity,22 and it is critical for the 
first line of oral defense. 
© 2013 Elsevier Editora Ltda. Todos os direitos res rvados.
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However, the complexity of the molecular composition 
of saliva has shown its importance in the systemic context. 
Saliva acts in the maintenance of the upper gastrointestinal 
tract pH.23 Additionally, it has defense factors such as anti-
bodies, cytokines, and growth factors that are associated with 
defense mechanisms and healing of inflammatory and infec-
tious processes not restricted to the mouth, but also including 
the oropharynx, esophagus, and stomach.24-28 
Salivary components interact with microorganisms and 
are important to control the composition of the oral micro-
biota.26 In this context, it is noteworthy that patients sedated 
in intensive care units often have alterations in salivary pat-
terns within just two weeks of hospitalization. It is observed 
that most of these patients have elevated Gram-negative 
oral microbiota, and that there is also a high occurrence of 
nosocomial pneumonia. Thus, a correlation between sali-
vary alterations and the manifestation of nosocomial pneu-
monia has been established.29 
Consequences of hyposalivation
In a systematic review of the subject, it was concluded that 
the flow rate of stimulated whole saliva below the normal 
range (< 1.0 mL/min of stimulated saliva) can be considered 
a predictor of caries.30 Regarding the degree of formation of 
dental calculus, it is known that it depends on the rate of 
salivary gland secretion, and a low salivary flow, associated 
with high salivary viscosity, would be a risk factor for peri-
odontal disease in the elderly.31 
Saliva also reflects the control of water consumption by 
the body, since when the body is dehydrated, the mouth be-
comes dry, and thirst is felt.32,33 It was observed that patients 
with severe hyposalivation tend to ingest more fluids during 
the day and night. Thus, they are likely to wake up at night 
more often to drink water and urinate. These frequent inter-
ruptions in nighttime sleep may favor insomnia, depression, 
and decreased memory, which affect the individual’s quality 
of life.34 
Moreover, it appears that severe hyposalivation is associ-
ated with increased occurrence of opportunistic fungal in-
fections in the mouth and oropharynx, stomatitis, difficulty 
to eat dry solids, dysphagia, burning sensation in the tongue 
and other parts of the oral mucosa, rampant caries, dental 
biofilm, instability of total dentures, dysgeusia, and halito-
sis.24,35-38 Another important aspect is also related to changes 
in eating habits, since the lack of saliva can reduce the plea-
sure of eating due to reduced sense of taste.38,39 Therefore, 
hyposalivation can result in physical, functional, and social 
impairment, affecting the quality of life of patients.10,40 
Regarding social and quality of life impairment, it is 
known that halitosis results in severe emotional disorders 
for patients.41,42 Fisher (1915) stated that bad breath can be 
sexually disgusting by indicating a variety of diseases.43 Sa-
liva represents a systemic body fluid that contains, among 
others, volatile organic compounds (VOCs). These com-
pounds are considered to be excellent indicators of environ-
mental and occupational exposure to chemicals, resulting 
from transdermal absorption, inhalation, or through food in-
take.44 VOCs from the saliva have been used in physiological, 
metabolomic, pharmacokinetic, toxicological, and forensic 
studies.44 Moreover, classic45,46 and current studies47,48 state 
that halitosis, in most cases, originates in the mouth and re-
sults from the metabolism of proteolytic anaerobic bacteria 
that release volatile sulfur compounds (VSCs).
Saliva is essential not only for the dilution of these com-
pounds, but also to provide the washing of the oropharynx, 
thus hindering the stagnation of organic matter and con-
Table 1 – Functions of saliva and its components.
Function Effect Active  
constituents 
Tissue repair  Healing of the oral  
and gastric mucosa 
and oropharynx
Epidermal growth 
factor (EGF)
Protection Lubrication of the 
mouth, oropharynx, 
and esophagus
Glycoproteins
Impermeabilization
Washing Water
Film formation
Tamponage Maintaining of 
unfavorable pH for 
micro-organism 
colonization
Phosphate, 
bicarbonate, and 
proteins
Neutralization of 
acidity
Digestion Formation of the food 
bolus
Mucin and water
Neutralization of 
esophageal contents
Phosphate and 
bicarbonate
Digestion of starch, 
proteins, and lipids
Amylase, protease, 
and lipase
Gustation Solubilization of 
molecules
Water
Maturation of taste 
buds
Gustine and Zn++
Antimicrobial  
action
Barrier Glycoprotein
Antibodies IgA, IgM, and IgG
Bacterial antagonism Lysozyme
Lactoferrin
Antiviral activity System of peroxidase, 
cystatin, mucin, and 
immunoglobulins
Antifungal activity Histatin, 
chromogranin A, and 
immunoglobulins
Tooth integrity Maturation of the 
enamel
Calcium and 
phosphate
Protection against 
demineralization
Mucins, calcium, and 
phosphate 
Remineralization Proteins rich in 
proline, staterine, 
calcium, and 
phosphate
Antioxidant 
defense 
system 
Prevents the formation 
of free radicals, 
eliminates existing 
free radicals, and 
repairs damage that 
has occurred
Uric acid, albumin, 
a-tocopherol, 
b-carotene, 
glutathione, and 
ascorbate
Cate, 1998;53 Amerogen and Veerman, 200254 (adapted).
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sequent formation of disagreeable gaseous compounds. It is 
worth noting that, depending on the capacity of volatilization 
of these compounds, they may or may not stimulate the hu-
man sense of smell. In this context, it is important to empha-
size that halitosis is a perceived change in the quality of the 
expiratory flow odor. Therefore, it can manifest as a signal, 
clinical halitosis, noticeable by the examiner and the people 
living with the individual that has halitosis, or as a symptom, 
i.e., subclinical halitosis, perceptible only by the patient.37
Subclinical halitosis represents a major challenge in rou-
tine clinical care, and causes major behavioral changes due 
to the patient’s belief that he/she has bad breath and the 
difficulty in establishing an accurate diagnosis.47 This situ-
ation may occur due to the low concentration of volatile 
compounds that excite the retronasal endings of the indi-
vidual, the sense of bad taste, or due to psychiatric disorders 
such as olfactory reference syndrome. Nevertheless, it ap-
pears that individuals with severe hyposalivation and asialia 
are vulnerable to gustatory sense-perceptive disorders that 
cause an unpleasant taste.49
Salivary flow assessment methods 
Tests used in the screening of a risk factor in the diagnosis 
of disease and in estimating the prognosis of a patient are 
important and costly phases of healthcare, and thus, they are 
noteworthy in clinical research.50
Several methods have been proposed for salivary flow as-
sessment. The choice of technique can be made by collecting 
whole saliva or saliva from a specific salivary gland. In addi-
tion, a sample can be obtained to evaluate salivary flow with 
and without stimulus. 
Whole saliva is a multiglandular secretion complex con-
sisting of gingival fluid, desquamated epithelial cells, micro-
organisms, products of bacterial metabolism, food debris, 
leukocytes, and mucus from the nasal cavity and the phar-
ynx.26 Its main advantage as part of the clinical evaluation is 
its ease-of-collection, and it is more often used than the indi-
vidualized sample.
Regarding the absence or presence of stimulation in the 
evaluation of salivary flow, the former will primarily reflect 
the functional status of the submandibular and sublingual 
glands, as these are mainly responsible for basal secretion. 
However, the nature of the stimulus will influence the type 
of response. Mechanical stimulation promotes a marked re-
sponse of the parotid gland, while gustatory stimulus acti-
vates the three pairs of major salivary glands. Table 2 shows 
different methods used to evaluate the rate of whole saliva 
flow. 
The passive flow method has been frequently used for 
the assessment of unstimulated saliva in clinical practice. 
With regard to stimulation, the mechanical stimulus has 
been more often used. A five-minute collection time has been 
widely used to evaluate the flow rate of unstimulated and 
stimulated saliva.
Table 3 shows the values  found for the flow rate of un-
stimulated whole saliva and under different types of stim-
uli, demonstrating the inter- and intra-patient variability. In 
addition to the technique, other factors may influence the 
results obtained, such as ambient temperature, relative air 
humidity, noises in the environment, time of sampling, du-
ration of collection, type of gustatory stimulation, consisten-
cy and size of the mechanical stimulus, fasting period, en-
vironment brightness, and even the season of the year.17,51,52 
These factors should be controlled as much as possible, and 
a test standardization should be used so as not to impair test 
result reliability. 
Table 4 shows the reference values  to classify patients as 
having severe or mild hyposalivation, or normosialia. Prior 
to collection, the patient should be instructed not to smoke, 
eat, drink, or perform any oral hygiene procedures in the 
two hours prior to the measurement. In addition, the patient 
should drink 300 mL of water two hours prior to collection 
of saliva to prevent the variability in body hydration from af-
fecting the results. Another important aspect concerns the 
standardization of time, i.e., flow monitoring should always 
be performed at the same time at which the first collection 
was performed, in order to avoid circadian variations. It is 
important that the clinical environment should be peaceful 
and that the patient should turn the phone off, because oth-
erwise the ring or other sound from the device can generate 
anxiety and alter the results. Regarding the evaluation se-
quence, the unstimulated saliva flow should be assessed first, 
and then the salivary flow rate in response to stimulation. 
The professional must strive to include this assessment as 
part of routine care in cases where the patient will be submit-
ted to treatments that can promote changes in salivary flow. 
As examples, prior to prescribing xerogenic medications in 
addition to chemo- and radioiodine therapy, in cases where 
patients will undergo radiation therapy in the cervical-ence-
phalic region, when suspecting and monitoring the progres-
sion of autoimmune diseases, and in other situations of den-
tal interest.
Conclusions
Saliva has many functions, including tissue repair, tampon-
age, mechanical protection, digestion, taste, antimicrobial ac-
tion, and maintenance of tooth integrity and the antioxidant 
defense system. Hyposalivation can result in physical, func-
tional, and social impairment, causing a negative impact on 
quality of life of patients. 
As an organic fluid, which varies according to a number 
of factors and circumstances, the use of the assessment of 
salivary flow in clinical practice requires standardization of 
its performance. 
Therefore, it is important for the rheumatologist to know 
the functions of saliva, the consequences of hyposalivation, 
and the methods of salivary flow assessment, since diagnos-
ing a patient with chronic hyposalivation is a challenge in 
clinical practice and serial evaluation of salivary flow is im-
portant for the diagnosis, prognosis, and monitoring of cer-
tain systemic and oral conditions. 
Conflicts of interest
The authors declare no conflicts of interest.
529R E V  B R A S  R E U M A T O L .  2 0 1 3 ; 5 3 ( 6 ) : 5 2 5 – 5 3 1
Table 2 – Proposed methods to evaluate whole saliva flow.
Type whole 
saliva 
Methods Measurement technique* Advantages Disadvantages
Without stimulus Passive 
drainage 
Saliva flows passively from 
the mouth into a graduated 
container
- Reproducible
- Reliable to measure salivary 
flow 
- Evaporation of saliva
Active 
drainage 
The saliva accumulated 
in the mouth must be 
regularly expectorated into 
a graduated container
- Reproducible
- Reliable to measure salivary 
flow 
- Evaporation of saliva
- There is a small stimulation 
of salivary flow in the act of 
spitting
Suction Saliva pooled on the mouth 
floor is vacuumed and 
accumulated in a graduated 
container
Does not depend on patient  
collaboration
- There is a small stimulation 
of salivary flow 
Absorption Swab, cotton, or gauze roll, 
pre-weighed, is inserted 
into the mouth for a certain 
amount of time and later 
weighed again
Detects the presence of 
saliva in the oral cavity, 
using a simple and easy 
method, especially in 
outpatient clinics and 
dental offices
- There is a small stimulation 
of salivary flow
- Less reliable method
- Alters the concentration of 
some salivary components
With stimulus Mechanical To chew paraffin, silicone, or 
unflavored chewing gum 
and spit the saliva into a 
graduated container
- Absence of side effects 
- There is no contamination 
of saliva with exogenous 
substances 
The frequency of mastications 
must be standardized with 
the aid of a metronome
Gustatory Applying citric acid to the 
lateral borders of the 
tongue
It can interfere with the 
analysis of some salivary 
components
Absorption -The swab is inserted into 
the mouth to be chewed 
for a certain time and 
subsequently weighed
Detects the presence of 
saliva in the oral cavity 
using a simple and easy 
method, especially in 
outpatient clinics and 
dental offices
There is a small stimulation of 
salivary flow
- Less reliable method
- Alters the concentration of 
some salivary components 
 Vissink et al, 200855 (adapted).
Table 3 – Flow rate of whole saliva.
Author (year) Flow rate Participants Type of stimulus
N/S W/S N Age Gender 
Becks and Wainwright (1943)56 0.32 (0.23) 2.0 (0.9)* 484     50* 5-49 M + F Paraffin
Bergdahl (2000)57 0.33 (0.26) 2.5 (1.06)  669 20-69 M Paraffin
0.26 (0.21) 2.02 (0.93)  758 20-69 F Paraffin
Engelen et al. (2003)58 0.45 (0.18) 1.22 (0.52)  8 19-33 M Paraffin
0.50 (0.24) Odor
2.69 (1.92) Citric acid 
0.35 (0.17) 1.06 (0.40)  14 19-33 F Paraffin
0.52 (0.20) Odor
2.06 (0.68) Citric acid 
Eliasson et al. (2006)59 0.3 (0.2) 2.4 (1.3)  46 22-82 M Paraffin
0.2 (0.2) 1.8 (0.8)  96 18-81 F Paraffin
N/S, no stimulus, W/S, with stimulus, M, male; F, female.
Flow rate mL / min (standard deviation).
Table 4 – Classification of whole saliva flow rate.
Whole saliva flow rate (mL/min) Very low Low Normal
Without stimulus < 0.1 0.1–0.25 > 0.25
With stimulus <0.7 0.7–1.0 > 1.0
Source: Ericsson and Hardwick, 1978.60
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